Mod-GRF (1-29) alternatives.
10 compounds compared to Mod-GRF (1-29), ranked by published evidence tier and regulatory status, not by what's marketed hardest.
Mod GRF 1-29 is chosen by people who specifically did not want the long-acting DAC version, so alternatives searches here are rarely about duration. They are about standing. It uses the same tetra-substituted GHRH(1-29) backbone as CJC-1295 without the albumin-binding linker, is not approved by the FDA or any major regulator, and falls under WADA Prohibited List class S2. The interesting fact for anyone comparing: its unmodified parent, sermorelin, was actually FDA-approved before being commercially discontinued, and the four engineered substitutions here exist only to slow enzymatic breakdown of that same sequence. Tesamorelin remains the one GHRH analog with a live approval.
Mod GRF 1-29 (commonly sold as "CJC-1295 without DAC") is a synthetic 29-amino-acid analog of growth hormone-releasing hormone (GHRH).
- 01TesamorelinA tierFDA-approvedEgrifta
Acts through the ghrh signalling pathway, like Mod-GRF (1-29). FDA-approved.
- 02SermorelinC tierResearch / preclinical
Acts through the ghrh signalling pathway, like Mod-GRF (1-29). Research / preclinical.
- 03CJC-1295F tierResearch / preclinical
Acts through the ghrh signalling pathway, like Mod-GRF (1-29). Research / preclinical.
- 04CJC-1295 DACF tierResearch / preclinical
Acts through the ghrh signalling pathway, like Mod-GRF (1-29). Research / preclinical.
- 05
- 06
- 07GHRP-1D tierResearch / preclinicalgrowth hormone-releasing peptide-1
Same category: growth hormone. Research / preclinical.
- 08GHRP-2D tierResearch / preclinical
Same category: growth hormone. Research / preclinical.
- 09GHRP-6D tierResearch / preclinical
Same category: growth hormone. Research / preclinical.
- 10HexarelinD tierResearch / preclinical
Same category: growth hormone. Research / preclinical.
An “alternative” here means a compound that shares Mod-GRF (1-29)'s mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.
PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.